As discussed previously (“New FDA Guidance Allows Biosimilar Applicants to Use Data From Outside the U.S. To Accelerate Their Approval in the ...

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces further compelling evidence from a multicenter, ...

Every year, sepsis kills roughly 350,000 adults in the United States alone, according to the Centers for Disease Control and ...

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces further compelling evidence from a multicenter, randomized controlled trial highlighting the clinical superiorit ...

In this Q&A, Mwango Kashoki, MD, MPH, SVP and global head of regulatory strategy at Parexel, breaks down the FDA's plausible ...

PBFT02 administration resulted in improvements in two disease progression biomarkers, as compared to natural history, reducing brain atrophy and ...

The traditional gold standard of clinical trials with a randomized, placebo-controlled design involving hundreds of patients ...

Patient- and physician-facing interventions together doubled the reductions in PPI use ...

An HHS spokesperson said Dr. Jay Bhattacharya had concerns about the paper’s methodology. Some current or former CDC ...

The acting CDC director cited concerns with the methodology, but the design has long been used to test vaccine effectiveness.

Abstract: In this article, we revisit a communication control co-design problem for a class of two-player stochas tic differential games on an infinite horizon. Each ‘player’ represents two active ...

Whole-blood transfusion has recently gained favor in the management of severe hemorrhage; however, data from large clinical trials evaluating its clinical effectiveness and safety are lacking. We ...